1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Novavax, Inc.
  6. Consensus
    NVAX   US6700024010

NOVAVAX, INC.

(NVAX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on NOVAVAX, INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) NOVAVAX, INC.
Analyst Recommendations on NOVAVAX, INC.
05/20BofA Securities Initiates Coverage on Novavax With Underperform Rating
MT
05/11B. Riley Lowers Novavax's Price Target to $181 from $203, Keeps Buy Rating
MT
04/26B. Riley Lowers Novavax's Price Target to $203 from $250, Notes Relatively Lowered Penetra..
MT
03/03HC Wainwright Adjusts Price Target on Novavax to $207 From $294, Reiterates Buy Rating
MT
03/02B. Riley Lowers Novavax's PT to $250 from $265 On Supply/Distribution, Notes Higher Near-T..
MT
02/23B. Riley Lowers Novavax's Price Target to $265 from $315 on Reduced Near-Term Estimates, M..
MT
02/15ANALYST RECOMMENDATIONS : Enbridge, GSK, PepsiCo, Moody's, Novavax...
More recommendations
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Last Close Price 46,13 $
Average target price 154,86 $
Spread / Average Target 236%
High Price Target 207,00 $
Spread / Highest target 349%
Low Price Target 35,00 $
Spread / Lowest Target -24,1%
Consensus detail
Consensus revision (last 18 months)